Efficacy and safety of plasma exchange and immunoadsorption plasmapheresis for neuromyelitis optica: Multicenter double-blind controlled study using dynamic allocatio
Not Applicable
- Conditions
- euromyelitis optica
- Registration Number
- JPRN-UMIN000009195
- Lead Sponsor
- Saitama Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
Patients considered to be due to brain lesions, the only local symptoms and disturbance of consciousness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in QOSI score on day 7 after the first course of blood purification therapy
- Secondary Outcome Measures
Name Time Method Anti-AQP4 antibody titer during evaluation period Initial effect Steroid pulse therapy efficacy rate Crossover study implementation rate Crossover study efficacy Adverse events